Page last updated: 2024-10-23

benzamide and Neoplasms

benzamide has been researched along with Neoplasms in 10 studies

benzamide : An aromatic amide that consists of benzene bearing a single carboxamido substituent. The parent of the class of benzamides.

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's1 (10.00)18.2507
2000's1 (10.00)29.6817
2010's5 (50.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Diamandis, P1
Wildenhain, J1
Clarke, ID1
Sacher, AG1
Graham, J1
Bellows, DS1
Ling, EK1
Ward, RJ1
Jamieson, LG1
Tyers, M1
Dirks, PB1
De, SK2
Zhu, H1
Li, W1
Shuai, W1
Liu, Y1
Yang, L1
Tan, Y1
Zheng, T1
Yao, H1
Xu, J1
Zhu, Z1
Yang, DH1
Chen, ZS1
Xu, S1
Adhikari, N1
Amin, SA1
Trivedi, P1
Jha, T1
Ghosh, B1
Wang, PF1
Wang, ZF1
Qiu, HY1
Huang, Y1
Hu, HM1
Wang, ZC1
Zhu, HL1
Adhami, F1
Safavi, M1
Ehsani, M1
Ardestani, SK1
Emmerling, F1
Simyari, F1
Chia, K1
Beamish, H1
Jafferi, K1
Gabrielli, B1
Kamal, A1
Suresh, P1
Ramaiah, MJ1
Mallareddy, A1
Imthiajali, S1
Pushpavalli, SN1
Lavanya, A1
Pal-Bhadra, M1
Nagao, M1
Nakayasu, M1
Aonuma, S1
Shima, H1
Sugimura, T1
Thraves, PJ1
Mossman, KL1
Brennan, T1
Dritschilo, A1

Reviews

1 review available for benzamide and Neoplasms

ArticleYear
HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches.
    European journal of medicinal chemistry, 2018, Sep-05, Volume: 157

    Topics: Animals; Benzamides; Dose-Response Relationship, Drug; Histone Deacetylase Inhibitors; Histone Deace

2018

Other Studies

9 other studies available for benzamide and Neoplasms

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutic

2007
Novel 4-chloro-N-phenyl Benzamide Derivatives as p38α Mitogenactivated Protein Kinase Inhibitors for Treating Cancer, COVID-19, and Other Diseases.
    Recent patents on anti-cancer drug discovery, 2023, Volume: 18, Issue:4

    Topics: Benzamides; COVID-19; Humans; Mitogen-Activated Protein Kinase 14; Neoplasms; Pharmaceutical Prepara

2023
Novel 4-chloro-N-phenyl Benzamide Derivatives as p38α Mitogenactivated Protein Kinase Inhibitors for Treating Cancer, COVID-19, and Other Diseases.
    Recent patents on anti-cancer drug discovery, 2023, Volume: 18, Issue:4

    Topics: Benzamides; COVID-19; Humans; Mitogen-Activated Protein Kinase 14; Neoplasms; Pharmaceutical Prepara

2023
Novel 4-chloro-N-phenyl Benzamide Derivatives as p38α Mitogenactivated Protein Kinase Inhibitors for Treating Cancer, COVID-19, and Other Diseases.
    Recent patents on anti-cancer drug discovery, 2023, Volume: 18, Issue:4

    Topics: Benzamides; COVID-19; Humans; Mitogen-Activated Protein Kinase 14; Neoplasms; Pharmaceutical Prepara

2023
Novel 4-chloro-N-phenyl Benzamide Derivatives as p38α Mitogenactivated Protein Kinase Inhibitors for Treating Cancer, COVID-19, and Other Diseases.
    Recent patents on anti-cancer drug discovery, 2023, Volume: 18, Issue:4

    Topics: Benzamides; COVID-19; Humans; Mitogen-Activated Protein Kinase 14; Neoplasms; Pharmaceutical Prepara

2023
Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities.
    European journal of medicinal chemistry, 2021, Apr-15, Volume: 216

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Binding Sites; Cell Cycle Checkpoints; Cell L

2021
Identification and Biological Evaluation of Novel Type II B-Raf
    ChemMedChem, 2018, 12-06, Volume: 13, Issue:23

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Line, Tumor; Drug Design; Female; Humans

2018
Synthesis, crystal structure, and cytotoxic activity of novel cyclic systems in [1,2,4]thiadiazolo[2,3-a]pyridine benzamide derivatives and their copper(II) complexes.
    Dalton transactions (Cambridge, England : 2003), 2014, Jun-07, Volume: 43, Issue:21

    Topics: Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cell Survival; Coordination Complexes; Copper;

2014
The histone deacetylase inhibitor MGCD0103 has both deacetylase and microtubule inhibitory activity.
    Molecular pharmacology, 2010, Volume: 78, Issue:3

    Topics: Benzamides; Cell Cycle; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Microtubules;

2010
Synthesis and biological evaluation of 4β-sulphonamido and 4β-[(4'-sulphonamido)benzamide]podophyllotoxins as DNA topoisomerase-IIα and apoptosis inducing agents.
    Bioorganic & medicinal chemistry, 2012, Mar-15, Volume: 20, Issue:6

    Topics: Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; Benzamides; Cell Cycle; Cell Line, Tumor; Come

2012
Loss of amplified genes by poly(ADP-ribose) polymerase inhibitors.
    Environmental health perspectives, 1991, Volume: 93

    Topics: 3T3 Cells; Aminobenzoates; Animals; Benzamides; Benzoates; Benzoic Acid; Cell Differentiation; Cell

1991
Differential radiosensitization of human tumour cells by 3-aminobenzamide and benzamide: inhibitors of poly(ADP-ribosylation).
    International journal of radiation biology and related studies in physics, chemistry, and medicine, 1986, Volume: 50, Issue:6

    Topics: Benzamides; Cell Line; Cell Survival; DNA Repair; Humans; Neoplasms; Poly(ADP-ribose) Polymerase Inh

1986